January 02, 2024 - Innoplexus and Amrit AG, members of the Partex NV Group, providers of innovative technology for health data analysis, and AIO Studien gGmbH, with expertise in clinical studies and registries for oncology research, are jointly announcing the start of a pilot project as part of the AIO data hub initiative. This pilot serves as a proof of concept and is part of an evaluation process to examine the feasibility and effectiveness of advanced technologies in oncology research. Expected results: February 2024.
Read more about this news. https://www.aio-portal.de/presse.html
Paris, June 2025 Partex has reduced the end-to-end timeline for antibody optimization from > 700 hours to 48 hours – a reduction by 93%. This enables faster, ...
Partnership builds on the successful launch of AK0707 collaboration, advancing next-generation oncology asset through AI-driven life cycle management Frankfur...
Frankfurt, Germany & Miami, FL, USA – March 17, 2025 – Partex NV and Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical compan...
Frankfurt, Germany, 20th February, 2025 – Partex is pleased to announce a strategic collaboration with Princeton Drug Discovery Ltd (PDD), a leading biotech c...
Pune, [13-02-2025]: Pimpri Chinchwad University (PCU) reaffirmed its commitment to technological excellence and academic innovation by organizing a two -day Fac...
Pressemitteilung vom 08.01.2025 Die Amrit AG, ein Unternehmen der Partex Gruppe - einem führenden Anbieter von KI-Lösungen im Gesundheitswesen - gibt heute de...
Partnership aims to expand therapeutic potential of proprietary autotaxin inhibitor through AI-driven approach Frankfurt, Germany – Date – Partex, a leader in ...
Frankfurt, Germany, 3 rd June 2024, 9am CET Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled to announce i...
Frankfurt, Germany, 23 April 2024 – Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled to announce its partnership wi...
Frankfurt, Germany; 28 March 2024 – Partex Group, a pioneer in AI-driven drug discovery, announces a collaboration with Althea DRF Lifesciences, an established ...
Innoplexus wins Horizon Interactive Gold Award for Curia App
Read More
